- Generic name
- Ticagrelor
- Strength
- 90 mg
- Dosage form
- Tablet
- Manufactured by
- Advanced Chemical Industries PLC
Acora 90 Tablet
About Acora 90 Tablet
Acora 90 is a 90 mg tablet containing ticagrelor, an anti-platelet medicine from Advanced Chemical Industries PLC. It is used in adults after acute coronary syndromes to help prevent serious heart-related events.
There are 13 brands of Ticagrelor listed in Bangladesh. The lowest listed price is Belinta 60 mg Tablet at ৳ 35.00 per unit.
What is Acora 90 Tablet?
Acora 90 is a tablet made by Advanced Chemical Industries PLC. Its active ingredient is ticagrelor, which belongs to a group of medicines called anti-platelet drugs. Ticagrelor works by reducing platelet activation and clumping in the blood. It is prescribed for adults who have had an acute coronary syndrome, such as unstable angina or a heart attack, including those treated with medicines alone or with procedures like angioplasty or bypass surgery. Acora 90 is taken together with aspirin. The doctor decides the dose, the course and how long treatment continues.
Uses of Acora 90
Acora 90 is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting. It is taken alongside daily aspirin as part of the treatment plan set by the doctor.
How to use Acora 90
Take Acora 90 exactly as the doctor prescribes. It is usually taken together with aspirin, and the doctor decides the aspirin strength that suits you. Swallow the tablet as directed. If you miss a dose, ask the doctor or pharmacist what to do; the product information advises taking only the next scheduled tablet and not doubling up. Do not stop or change the medicine on your own, because stopping can raise the risk of heart attack, stent thrombosis and death. Ask the doctor about the dose and course.
Side effects of Acora 90
Common side effects that have been reported with ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. Because it affects platelets, bleeding is a particular concern. Call the doctor promptly if you notice unusual or prolonged bleeding, breathing difficulty, or any side effect that worries you or does not settle. The doctor can advise whether you need review or a change in treatment.
Safety and precautions
Acora 90 increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain. It is not recommended in pregnancy, and it should not be used while breastfeeding unless the doctor decides the benefits outweigh the risks. It is not for people with moderate to severe liver problems or with allergies to the ingredients. Some other medicines, including certain antifungals, antibiotics and seizure medicines, should not be combined with it. Always tell the doctor and pharmacist about all medicines you take, and ask them first before starting or stopping anything.
Frequently asked questions
Can Acora 90 be used during pregnancy or breastfeeding?
It is not recommended during pregnancy. When breastfeeding, a decision has to be made between stopping breastfeeding and stopping the medicine, weighing the benefits of each. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding so they can advise you.
What is Acora 90 used for and what kind of medicine is it?
Acora 90 is an anti-platelet tablet containing ticagrelor. It is used in adults after an acute coronary syndrome, such as unstable angina or a heart attack, to help prevent atherothrombotic events. It works by reducing platelet activation and clumping, and it is taken together with aspirin as part of the doctor's plan.
What side effects should I watch for, and when should I call the doctor?
Watch for shortness of breath, unusual or prolonged bleeding, headache, dizziness, nausea, diarrhoea, back pain and fatigue. Call your doctor promptly if bleeding does not stop, you have trouble breathing, or any side effect is severe or worrying. Do not stop the medicine on your own before speaking to your doctor.
Can I stop taking Acora 90 on my own?
No. Stopping ticagrelor increases the risk of heart attack, stent thrombosis and death. If you have side effects or concerns, speak to your doctor, who will decide whether to change your treatment. Always ask your doctor or pharmacist before making any change.
Indications
Pharmacology
Dosage & Administration
A patient who misses a dose of Ticagrelor should take only one 90 mg tablet (the next dose) at its scheduled time. Patients treated with Clopidogrel can be directly switched to Ticagrelor if needed. Switching from prasugrel to ticagrelor has not been investigated.
Treatment is recommended for up to 12 months unless discontinuation of Ticagrelor is clinically indicated. Ticagrelor can be administered with or without food.
Interaction
CYP3A inducers: Avoid use with potent inducers of CYP3A (e.g., rifampin, dexamethasone, phenytoin,carbamazepine and phenobarbital).
Aspirin: Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness ofTicagrelor.
Simvastatin, Lovastatin: Ticagrelor will result in higher serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.
Digoxin: Because of inhibition of the P-glycoprotein transporter, monitor digoxin levels with initiation of or any change in ticagrelor therapy.
Other Concomitant Therapy: Ticagrelor can be administered with unfractionated or low-molecular-weight heparin, GPIIb/llla inhibitors, proton pump inhibitors, beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers.
Contraindications
- Hypersensitivity to Ticagrelor or to any of the excipients
- Active pathological bleeding (peptic ulcer)
- History of intracranial haemorrhage
- Moderate to severe hepatic impairment
- Co-administration of Ticagrelor with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, nefazodone, ritonavir, and atazanavir)
Side Effects
Pregnancy & Lactation
Nursing mothers: Available pharmacodynamic/toxicological data in animals have shown excretion of Ticagrelor and its active metabolites in milk. A risk to newborns/infants cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from ticagrelor therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the women.
Precautions & Warnings
Concomitant Aspirin Maintenance Dose: Use of Ticagrelor with maintenance doses of aspirin above 100 mg decreased the effectiveness of Ticagrelor. Therefore, after the initial loading dose of aspirin (usually 325 mg), use Ticagrelor with a maintenance dose of aspirin of 75-100 mg.
Moderate Hepatic Impairment: Ticagrelor has not been studied in patients with moderate hepatic impairment.
Discontinuation of Ticagrelor: Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stent thrombosis, and death.
Overdose Effects
Storage Conditions
Alternative brands of Ticagrelor
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.